Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
The industrial food matrix is not merely delivering poor nutrition. It is executing a systemic epigenetic intervention on ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that eliminates aging. Key takeaways from special elections in Arizona and Georgia How to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results